Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy

NCT00110500 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sangamo Therapeutics